Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis
- 4 May 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 14 (6), 528-532
- https://doi.org/10.1007/s00520-006-0066-1
Abstract
This review focuses on the value of several groups of agents for the prevention and treatment of mucositis. The review refers to alimentary mucositis as a generalized term that includes oral mucositis and gastrointestinal mucositis. This paper is part of the systematic review made by the mucositis study group which operates in the Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Several new guidelines are suggested in this review as an update to the primary systematic review that was published by the same group in 2004.This publication has 24 references indexed in Scilit:
- Opioid Rotation in Children with CancerJournal of Palliative Medicine, 2004
- Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantationTransplantation and Cellular Therapy, 2004
- Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositisCancer, 2004
- Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositisSupportive Care in Cancer, 2004
- Topical Ketamine in the Treatment of Mucositis PainPain Medicine, 2003
- Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemiaPesquisa Odontológica Brasileira, 2003
- Risk factors for ulcerative oral mucositis in cancer patients: unanswered questionsOral Oncology, 2002
- Effect of topical morphine for mucositis‐associated pain following concomitant chemoradiotherapy for head and neck carcinomaCancer, 2002
- Prophylaxis of Radiation-Associated Mucositis in Conventionally Treated Patients With Head and Neck Cancer: A Double-Blind, Phase III, Randomized, Controlled Trial Evaluating the Clinical Efficacy of an Antimicrobial Lozenge Using a Validated Mucositis Scoring SystemJournal of Clinical Oncology, 2002
- Oral mucositis--current concepts and management.2002